Immuneel and Arogya Finance launch India’s first zero cost EMI program for Qartemi CAR-T Cell…
Immuneel Therapeutics, India's pioneering cell and gene therapy company, announced a strategic partnership with Arogya Finance to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Qartemi
Immuneel raises ₹100 crore in Series B funding to expand CAR-T therapy operations and global…
Immuneel Therapeutics outlines plans to scale manufacturing, advance its cell and gene therapy pipeline, commercialise Qartemi…
Blood cancers dominate CAR-T pipeline: GlobalData
According to GlobalData’s Drugs Database, blood cancers account for over half of all CAR-Ts in the active pipeline* and make up…
Immuneel Therapeutics launches Qartemi, a CAR T-cell therapy for Non-Hodgkin’s Lymphoma
Immuneel has collaborated with hospitals including Narayana Health, Apollo Hospitals, CMC Vellore, Manipal Hospitals among others…